Prologis, Inc. (NYSE: PLD), a leader in the bio-tech space, witnessed various movements and adjustments by key stakeholders and politicians including Rep. Thomas H. Kean, Jr. and Rep. Gilbert Ray Cisneros, Jr. Changes in stock positions were conducted by a number of financial institutions and asset management firms like Mizuho, Knights of Columbus Asset Advisors LLC, and Stevens Capital Management LP amidst noteworthy market fluctuations. Citigroup set a new price target of $140.00 for Prologis. Despite a slight stock decline, Prologis trading volume surged to $682 million. Q2 Earnings Conference Call highlighted strong performance despite market challenges and the company achieved Q2 FFO and revenue estimates. A significant leadership transition was announced along with some changes in earnings guidance. However, the company managed to surpass earnings and revenue estimates while raising core FFO guidance. Prologis also had a strong participation in industry conferences shedding light on vital industry trends.
Prologis PLD News Analytics from Wed, 16 Oct 2024 07:00:00 GMT to Sat, 26 Jul 2025 20:23:39 GMT - Rating 5 - Innovation 4 - Information 7 - Rumor -2
